Navigation Links
Lexicon Presents LX4211 Clinical Data at European Association for the Study of Diabetes Annual Meeting
Date:9/13/2011

THE WOODLANDS, Texas, Sept. 13, 2011 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced today that the company is presenting clinical data this week at the European Association for the Study of Diabetes (EASD) annual meeting in Lisbon, Portugal.

Data from the mechanistic study being presented at the EASD meeting demonstrated that a single dose of LX4211 significantly increased circulating levels of GLP-1 (active and total) and PYY, important regulators of glycemic and appetite control.  For more information on this program or to download a copy of the presentation from the EASD meeting, please visit www.lexpharma.com.

About Lexicon

Lexicon is a biopharmaceutical company focused on discovering breakthrough treatments for human disease.  Lexicon currently has four drug programs in mid-stage development for diabetes, irritable bowel syndrome, carcinoid syndrome and rheumatoid arthritis, all of which were discovered by Lexicon's research team.  Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets.  Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs.  For additional information about Lexicon and its programs, please visit www.lexpharma.com.

Safe Harbor Statement

This press release contains "forward-looking statements," including statements relating to Lexicon's clinical development of LX4211, including characterizations of the results of and projected timing of clinical trials of such compounds, and the potential therapeu
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Lexicon Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference
2. Lexicon Pharmaceuticals to Present at Stifel Nicolaus Healthcare Conference
3. Lexicon Pharmaceuticals to Present at the Wedbush 2011 Life Sciences Management Access Conference
4. Lexicon Announces Publication of Results From the Phase 2 Trial of LX1031 in Patients With Irritable Bowel Syndrome in Journal of Gastroenterology
5. Phase 2 Trial of Lexicons LX1032, Telotristat Etiprate, Shows Positive Results in Carcinoid Syndrome
6. Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Second Quarter Results
7. Lexicons IBS Drug Candidate, LX1033, Successfully Completes Phase 1 Clinical Trial
8. Lexicon Presents LX4211 Mechanism of Action Data at American Diabetes Association Meeting and Announces Commencement of Phase 2b Clinical Trial in Type 2 Diabetes
9. Lexicon Pharmaceuticals Announces Webcast of 2011 Annual R&D Day
10. Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 First Quarter Results
11. Lexicon to Provide First Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 2013   Polymer Technology Systems, Inc. ... Group to integrate the CardioChek ® ... by health systems across the country. The CardioChek ... distributed through Hanson Medical Systems , offers ... LDL cholesterol, triglycerides, and glucose. (Logo: ...
(Date:6/17/2013)... , June 17, 2013  Hanger, Inc. (NYSE: ... credit agreement that increases its senior secured facilities to ... million previously.  The new credit agreement includes a $200 ... loan facility.  The previous credit agreement was comprised of ... million term loan.  Each new facility matures on June ...
(Date:6/17/2013)... 2013 BioMed Realty Trust, Inc. (NYSE: ... declared a second quarter 2013 dividend of $0.235 per share ... dividend of $0.94 per common share. The ... stockholders of record at the close of business on June ... BioMed Realty delivers optimal real estate solutions for biotechnology ...
Breaking Medicine Technology:Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 2Polymer Technology Systems, Inc. to Provide Point-of-Care Lipid Testing to Aegis Health Group's Hospital Clients 3Hanger Enters New 5-Year Credit Agreement to Refinance Senior Secured Credit Facilities 2Hanger Enters New 5-Year Credit Agreement to Refinance Senior Secured Credit Facilities 3BioMed Realty Trust Declares Second Quarter 2013 Common Stock Dividend 2BioMed Realty Trust Declares Second Quarter 2013 Common Stock Dividend 3
(Date:6/18/2013)... The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) joined ... Emergency Plan for AIDS Relief (PEPFAR) to mark PEPFAR’s ... the global effort to eliminate pediatric HIV/AIDs. U.S. ... June 2013, one million babies globally have been born ... in 2003, EGPAF has been a key implementer of ...
(Date:6/18/2013)... June 18, 2013 A new $119 ... The burgeoning aquaculture industry is redefining the way consumers ... the most acclaimed personal culinary chefs on the Emerald ... benefits of sustainable seafood and the promising industry of ... these days. Many consumers strive to fully partake in ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 New York magazine ... to its “Best Doctors” list, up from 129 last ... City. The new issue also lists 52 additional doctors who ... on a strategic growth trajectory. The “Best Doctors” issue, which ... the June 24 print issue and is available online at ...
(Date:6/18/2013)... to keep their scheduled medical appointments and their ... listens, explains things clearly and knows them as a ... suggests. , "If people feel their doctor really knows ... has their best interests at heart and may be ... Tabor E. Flickinger, M.D., M.P.H., a fellow in the ...
(Date:6/18/2013)... gather data for the FDA to support the need ... the United States. The University of Rochester Medical Center ... Journal of Neurotrauma that it might be clinically ... Jeffrey J. Bazarian, M.D., M.P.H., an associate professor of ... show that measuring a combination of two proteins released ...
Breaking Medicine News(10 mins):Health News:One Million Babies Born HIV-free Signals Major Milestone in Global Effort to Eliminate Pediatric AIDS 2Health News:One Million Babies Born HIV-free Signals Major Milestone in Global Effort to Eliminate Pediatric AIDS 3Health News:New $119 Million Industry Swimming Up the East Coast 2Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 2Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 3Health News:Respect may be the key to stopping patient 'no shows' 2
... manipulation of inheritable genes to enable people to produce ... family relationships and on being human, warns a leading ... diseases hold out great hope for IGM technology, which ... as Huntington’s Disease and schizophrenia on to their children.// ...
... the risk of pancreatic cancer in both sexes,while moderate ... obese individuals,says Dr. Dominique S. Michaud the head ... National Cancer Institute in Rockville, Maryland and colleagues collected ... 75 years of age, who participated in the Health ...
... itself by growing new cells after a heart attack. This surprising ... Piero Anversa and colleagues of the New York Medical College in ... divide after a heart attack.// , ... died within a few days of having a heart attack and ...
... According to researchers, patients suffering from Angina may have ... doses of antibiotics. Angina, a common cardiovascular disorder affecting ... chest pain caused by blood vessels too clogged to ... Current treatment involves either medication or for more serious ...
... week could significantly increase the success rate of pig-to-human ... indicated that rejection of animal cells and organs by ... presence of the gene alpha 1,3 galactosyl transferase. The ... to the surface of pig cells, flagging them up ...
... technique to keeping heart arteries flowing easily after angioplasty ... major weakness of the common procedure.Doctors released the ... drug-coated stent. In testing on 30 patients over three ... an accomplishment almost unheard of in medicine.// ,More ...
Cached Medicine News:Health News:Perfect babies boon or a bane? 2Health News:Antibiotic, Gene Therapy Help Treat Angina 2Health News:Antibiotic, Gene Therapy Help Treat Angina 3Health News:Xenotransplantation “breakthrough” 2Health News:A ray of hope in Angioplasty dilemma 2
... The ACS:180 SE is ... ACS:180 PLUS, consisting of important ... further simplify routine operation and ... represents the "Next Generation" ACS:180. ...
... Chrono-log's wide range of Platelet aggregometers ... to meet particular needs. Single, dual ... with chart recorder outputs or digital ... Chrono-log Optical aggregometers, which measure platelet ...
... Platelet aggregometers allows to choose the ... Single, dual and four sample units ... or digital computer outputs. In addition ... measure platelet aggregation in platelet-rich-plasma (PRP), ...
... The PAP-4 is a four channel Platelet ... available: von willebrand assay (Ristocetin cofactor), platelet ... also be used for the evaluation and ... channels allow four tests to be run ...
Medicine Products: